Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Generate Biomedicines has completed its IPO, raising an impressive $400 million that makes it the largest listing for a biotech on the Nasdaq so far this year. Incubated by investment group Flagship ...
Whether you are revisiting the 2014 classic or preparing for the home release of the 2025 Five Nights at Freddy’s 2 movie, mastering the massive roster of animatronics is the only way to survive until ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results